HgCl2 challenge in Brown Norway rats lead to dermatitis instead of arthritis

被引:0
|
作者
K. Schümann
A. Lebeau
T. Ettle
O. Adam
机构
[1] TU-München,Zentralinstitut für Ernährung und Lebensmittelforschung, Abteilung Biochemie
[2] Pathologisches Institut der LMU,Fachgebiet Tierernährung und Leistungsphysiologie
[3] Wissenschaftszentrum Weihenstephan,undefined
[4] Walther-Straub-Institut für Pharmakologie der LMU,undefined
来源
关键词
Adjuvant; Arthritis; Dermatitis; Rat;
D O I
暂无
中图分类号
学科分类号
摘要
A wide range of methods are described to produce adjuvant arthritis in rats by antigen exposure. Studies using these methods are rarely controlled histologically though the result can be paw dermatitis instead of arthritis. Three male Brown Norway rats were injected s.c. with HgCl2 (1 mg Hg/kg body weight) on five alternating days following closely a well described scheme for induction of adjuvant arthritis. Extent of paw oedema was assessed sonographically. Location and extent of inflammatory responses were inspected histologically. Swollen reddish and painful paw oedema started to develop on day 13 increasing until day 16. Oedema increased skin-to-bone and skin-to-skin distance across the inflamed paws significantly. Histological examination on day 16 revealed marked dermatitis with dense cellular infiltrates, single cell necrosis and fibrin exudation. In contrast, no inflammatory responses were observed in the joints. Use of a well described scheme for induction of adjuvant arthritis produced dermatitis of the paw with identical time course, clinical and sonographic appearance as expected for arthritis. This observation strongly suggests the need to check the histology on location and the kind of inflammatory response when a model for adjuvant arthritis is altered or used for the first time.
引用
收藏
页码:393 / 395
页数:2
相关论文
共 50 条
  • [1] HgCl2 challenge in Brown Norway rats lead to dermatitis instead of arthritis
    Schümann, K
    Lebeau, A
    Ettle, T
    Adam, O
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (05) : 393 - 395
  • [2] COMPLEMENT STUDIES IN BROWN NORWAY RATS WITH HGCL2 INDUCED IMMUNE GLOMERULONEPHRITIS
    CAPRON, M
    AYED, K
    DRUET, E
    SAPIN, C
    MANDET, C
    DRUET, P
    GIRARD, JF
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1980, 10 (02) : 6 - 6
  • [3] IMMUNE TYPE GLOMERULONEPHRITIS INDUCED BY HGCL2 IN THE BROWN NORWAY RAT
    DRUET, P
    DRUET, E
    POTDEVIN, F
    SAPIN, C
    ANNALES D IMMUNOLOGIE, 1978, C129 (06): : 777 - 792
  • [4] AUTOIMMUNITY INDUCED BY HGCL2 IN BROWN-NORWAY RATS .1. PRODUCTION OF MONOCLONAL-ANTIBODIES
    HIRSCH, F
    KUHN, J
    VENTURA, M
    VIAL, MC
    FOURNIE, G
    DRUET, P
    JOURNAL OF IMMUNOLOGY, 1986, 136 (09): : 3272 - 3276
  • [5] HGCL2 (HG) INJECTIONS AT BIRTH INDUCE SPECIFIC TOLERANCE TO MERCURY DISEASE IN BROWN-NORWAY (BN) RATS
    FILLION, J
    KUHN, J
    DRUET, P
    BELLON, B
    FASEB JOURNAL, 1994, 8 (04): : A521 - A521
  • [6] Low dose mercuric chloride (HgCl2) induces resistance in Brown-Norway (BN) rats to full dose HgCl2 by up-regulation of interferon gamma (IFN-γ).
    Szeto, CC
    Gillespie, KM
    Mathieson, PW
    KIDNEY INTERNATIONAL, 1999, 55 (06) : 2554 - 2554
  • [7] SYSTEMIC AUTOIMMUNE-DISEASE INDUCED BY INHALATION OF HGCL2 IN THE BROWN-NORWAY RAT
    BERNAUDIN, JF
    DRUET, P
    MASSE, R
    BIGNON, J
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1979, 119 (04): : 201 - 201
  • [8] IMMUNE-COMPLEX TYPE DISEASE INDUCED BY HGCL2 IN BROWN-NORWAY RATS - GENETIC-CONTROL OF SUSCEPTIBILITY
    SAPIN, C
    MANDET, C
    DRUET, E
    GUNTHER, E
    DRUET, P
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1982, 48 (03): : 700 - 704
  • [9] THE ROLE OF INTERLEUKIN-10 (IL-10) IN HGCL2 INDUCED AUTOIMMUNITY IN BROWN-NORWAY (BN) RATS
    BARAN, D
    VENDEVILLE, B
    RUBIN, E
    LUU, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 822 - 822
  • [10] CLOTTING ABNORMALITIES DURING THE COURSE OF IMMUNE TYPE GLOMERULONEPHRITIS INDUCED BY HGCL2 IN THE BROWN NORWAY RAT
    MICHAUD, A
    SAPIN, C
    AIACH, M
    DRUET, P
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1980, 10 (02) : 25 - 25